SBIR/STTR Research Award
EAP-DERIVED MONOCLONAL ANTIBODIES FOR ""WISH LIST"" HAMSTER IMMUNE TARGETS INVOLVED IN CELL ACTIVATION.
Award amount
$600,000Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SILVER LAKE RESEARCH CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- C9FZMJCTQFP4
- Solicitation number
- PHS2021-1
- Topic code
- 94
Research abstract
EAP-Derived Monoclonal Antibodies for Immune Targets Involved in Cell Activation
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- EAP-Derived Monoclonal Antibodies for Phenotyping Immune Cells of Animal Model of Disease
- EAP-DERIVED MONOCLONAL ANTIBODIES FOR PHENOTYPING GUINEA PIG IMMUNE CELLS.
- EAP-Derived Monoclonal Antibodies or Phenotyping Immune Cells of Animal Models of Disease
- Rapid LFIA blood test for SCD using highly specific monoclonal antibodies
- Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens
Research funding history
12 SBIR/STTR records share this UEI (2006–2023). Reported award amounts total $9,165,947. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Environmental Protection Agency